Email Updates

You are here

Home

14 JULY 2023 VOLUME 25 ISSUE 28

Media Coverage

  • Right-Wing Politicians Are Stoking Renewed Moral Panic About HIV

    In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the lowest numbers of new HIV diagnoses in decades. New HIV infections were down 12 percent from 2017 to 2021, thanks to successful prevention efforts, including PrEP. The end of the epidemic may finally be in our grasp. Prevention methods now include a medication called PrEP (for pre-exposure prophylaxis), and uptake has never been higher.

    July 13, 2023
    General
    STAT

  • AIDS Can Be Ended by 2030 With Investments in Prevention and Treatment, UN Says

    It is possible to end AIDS by 2030 if countries demonstrate the political will to invest in prevention and treatment and adopt non-discriminatory laws, the United Nations said on Thursday. In 2022, an estimated 39 million people around the world were living with HIV, according to UNAIDS, the United Nations AIDS program. HIV can progress to AIDS if left untreated.

    July 13, 2023
    General
    Reuters

  • Scientists Discover Mechanism of Cell Death in People Living With HIV

    Professor Simona Stäger's team has made a breakthrough in the study of the human immunodeficiency virus (HIV). The researchers have identified the mechanism by which memory CD4+ T lymphocytes-;cells that play a major role in our immune response-;are predisposed to cell death in people living with HIV. The team's findings have just been published in JCI Insight.

    July 13, 2023
    General
    News Medical

  • Encouraging Preliminary Results in African Phase I HIV Vaccine Trial

    The multisite Phase I HIV-CORE 006 HIV vaccine clinical trial, run by the Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT), has concluded successfully. Preliminary analysis of the immunological trial results demonstrates the induction of high frequencies of broadly specific T cells that recognise functionally conserved regions on HIV-1 and are therefore more protective.

    July 12, 2023
    HIV Vaccine
    Mirage News

  • PrEP Initiation, Continuation Feasible in Range of Clinical Settings

    Initiation, monitoring, and continuation of pre-exposure prophylaxis (PrEP) was found to be feasible in a variety of clinical settings through a range of providers after the implementation of a provincial program in Alberta, Canada, according to the results of a study published in the Journal of the Association of Medical Microbiology and Infectious Disease.

    July 11, 2023
    PrEP
    Pharmacy Times

  • An Old Drug Offers a New Way To Stop STIs

    A promising line of attack against sexually transmitted infections puts a cheap and widely available medication to a new use. The treatment – a form of post-exposure prophylaxis, or PEP – is a dose of the antibiotic doxycycline taken in the hours immediately after sex which works to extinguish an STI before it leads to symptoms or spreads to others.

    July 11, 2023
    General
    NPR

  • UNAIDS Advocates Equal Access to HIV Treatments, Services

    The Joint United Nations Programme on HIV/AIDS (UNAIDS), has stressed the need to address the issues of stigma and discrimination against people living with HIV in Nigeria and ensure equal access to HIV treatment and services by the key population.

    July 11, 2023
    General
    The Guardian

  • The Rev. Stephen Pieters, Who Helped Shift Views on AIDS, Dies at 70

    Deep into the AIDS crisis in October 1985, a prominent Los Angeles minister named Stephen Pieters traveled to a television studio for a satellite-link interview that his friends begged him to avoid. On the other end was the Pentecostal televangelist Tammy Faye Bakker, of the Charlotte-based PTL Television Network. Then at her peak, with more than 13 million viewers, she and her broadcaster husband, Jim, held great sway with conservative Christian followers whose beliefs were seen as sharply at odds with the gay community and AIDS patients such as Rev. Pieters.

    July 11, 2023
    General
    Washington Post

  • Novel Drugs That Turn HIV Against Itself Might Clear Infected Cells From the Body

    Scientists from the pharmaceutical company Merck have published the first detailed data about a subset of the familiar non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs that, in addition to inhibiting HIV’s ability to copy itself, may be able to kill off HIV-infected cells by causing the virus to ‘poison’ the cells it depends on for replication.

    July 10, 2023
    General
    aidsmap

  • Culturally Tailored Approaches Needed to Improve Access to PrEP for HIV

    In a review of 19 prior studies, investigators said that international migrants are disproportionately affected by HIV. In their study, published in Lancet Public Health, the investigators noted that culturally tailored approaches and access to pre-exposure prophylaxis (PrEP) for individuals who are from different backgrounds should be considered.

    July 10, 2023
    PrEP
    Pharmacy Times

  • Monoclonal Antibodies as Pre-exposure Prophylaxis May Be Cost-Effective Approach to Reduce Severe Outcomes in COVID-19

    Pre-exposure prophylaxis (PrEP) with long-acting and neutralizing SARS-CoV-2 monoclonal antibodies (mAbs) may prevent SARS-CoV-2 infection at a cost-saving outcome; however, current drug prices must still be adjusted to maintain the cost-effective ratio, according to the results of a study published in JAMA Network Open. Use of mAbs PrEP was cost-saving for people at high risk of severe COVID-19 if the cost was $275 and showed a minimum efficacy of 75 percent.

    July 10, 2023
    PrEP
    Pharmacy Times

  • COVID-19 Diagnoses Linked to Rise in STI Rates in Some US Counties

    Higher rates of COVID-19-related mortality and incident infections are associated with county-level increases sexually transmitted infection (STI) rates in the United States, according to study findings published by Sexually Transmitted Diseases.

    July 10, 2023
    General
    Infectious Disease Advisor

  • What Happens When HIV Becomes a Crime

    James’ life was irrevocably changed the day his name, photo, address and place of work were plastered on a news website beneath the accusation that he was being charged with infecting his former partner with HIV. It wasn’t the start of the living nightmare he found himself in — that had begun two years earlier when the police in England interviewed James following an allegation being made against him by his former partner.

    July 10, 2023
    General
    POLITICO

  • Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage

    It is an unfortunate reality that the communities most susceptible to an infectious disease are also the least likely to have access to necessary care and treatment. New data, published by AIDSVu, revealed the 2022 usage of HIV preexposure prophylaxis (PrEP) by race and ethnicity across the United States.

    July 8, 2023
    General
    AJMC

  • How an LGBTQ Clinic in Uganda Keeps Going Amid Rising Homophobic Violence

    In the six weeks since Uganda’s president signed the country’s Anti-Homosexuality Act (AHA) into law, the LGBTQ community and its supporters in Kampala, Uganda’s capital and largest city, have faced escalating harassment and security threats. The regulation has led to more than 300 human rights violations against people suspected of being gay in Uganda, according to reporting from CNN.

    July 8, 2023
    General
    Vox

  • The Potential Effect of an ACA Legal Fight on HIV Prevention

    The latest legal battle over the Affordable Care Act centers on its mandate that private insurers cover preventive services, including drugs that prevent HIV infection. The retail price of those drugs can be as much as $6,000 for a 90-day supply, putting it out of reach for many who would benefit from it. The 19th News’ health reporter Shefali Luthra joins John Yang to discuss.

    July 8, 2023
    PrEP
    Thirteen

Published Research

Announcements